Ascletis is an innovative R&D driven biotech with two commercial products and listed on Hong Kong Stock Exchange (Ascletis, 1672.HK). Ascletis’ mission is to address unmet medical needs in three therapeutic areas: viral, cancer and fatty liver diseases. Led by a management team with deep expertise and a proven track record, Ascletis has developed a fully integrated platform covering the entire value chain from discovery and development to manufacturing and commercialization.

Biotechnology

Ascletis

This department focuses on high-level governance and strategic direction for the organization.

Executive Oversight

Ascletis' Leadership Team includes Yuemei Yan and 3 others.

People (0)

Jobs (0)

Other teams

Leadership Team